Sever Pharma Solutions

France

https://www.severpharmasolutions.com

Drug Product

Chemistry, Manufacturing and Controls

Clinical Trial Supply & Logistics

Regulatory, Tech Transfer & Support Services

Manufacturing & Lab Equipment

Analytical & Bioanalytical Services

Company Overview

About

Sever Pharma Solutions is a specialized CDMO focused on high-potent and cytotoxic drug products (up to OEB6), polymer-based controlled-release delivery systems (implants, vaginal rings), hot melt extrusion for bioavailability enhancement, and prefilled syringe/autoinjector aseptic fill-finish. With sites in Malmö (Sweden) and Putnam (Connecticut, USA), they offer end-to-end services from formulation development through commercial manufacturing.

Key Expertise

high-potent APIs (up to OEB6), polymer-based controlled-release delivery systems, hot melt extrusion (HME), ocular implants, prefilled syringe and autoinjector assembly

Therapeutic Areas

Ophthalmology

Dermatology

Quick Facts

HQ:France

Capabilities & Services

Core Capabilities

Small Molecule Drug Product
Oral Solid Dose
Formulation Development

Dosage Forms

Oral Solid Dose

Prefilled Syringe

Containment Capabilities

Cytotoxic / ADC Handling

DEA Schedule II-V

Production Scales

R&D / Pre-clinical

Pilot Scale

Clinical

Commercial Scale

Annual Capacity

Small Batch / R&D (< 100 kg/year)

Medium Clinical (100 - 1,000 kg/year)

Commercial (1,000 - 10,000 kg/year)

Markets Served

Europe

Manufacturing Facilities

1 site worldwide

Sever Pharma Solutions - France Facility

France

View on Map

Site Capabilities

Quality Control

Stability Testing

Method Development

Certifications

FDA Registration

U.S. Food and Drug Administration

EMA GMP Certificate

European Medicines Agency

Customer Reviews

No reviews available yet.

Company Documents

No documents available.

Send Inquiry

Please log in to send an inquiry to this CDMO.